Andrea Heger

499 total citations
24 papers, 376 citations indexed

About

Andrea Heger is a scholar working on Biochemistry, Management of Technology and Innovation and Hematology. According to data from OpenAlex, Andrea Heger has authored 24 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biochemistry, 10 papers in Management of Technology and Innovation and 9 papers in Hematology. Recurrent topics in Andrea Heger's work include Blood transfusion and management (12 papers), Blood donation and transfusion practices (10 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (6 papers). Andrea Heger is often cited by papers focused on Blood transfusion and management (12 papers), Blood donation and transfusion practices (10 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (6 papers). Andrea Heger collaborates with scholars based in United States, Germany and Austria. Andrea Heger's co-authors include Jürgen Römisch, Sue Jordan, Katharina Pock, Andrea Buchacher, Djuro Josić, Tom Grunert, Darrell J. Triulzi, Andrew Bailey, Christoph Kannicht and Gerhard Grüber and has published in prestigious journals such as Electrophoresis, Transfusion and Thrombosis Research.

In The Last Decade

Andrea Heger

23 papers receiving 326 citations

Peers

Countries citing papers authored by Andrea Heger

Since Specialization

Citations

This map shows the geographic impact of Andrea Heger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Heger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Heger more than expected).

Fields of papers citing papers by Andrea Heger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Heger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Heger. The network helps show where Andrea Heger may publish in the future.

Co-authorship network of co-authors of Andrea Heger

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Heger. A scholar is included among the top collaborators of Andrea Heger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Heger. Andrea Heger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of current commercially‐available devices to thaw pooled, solvent/detergent‐treated human plasma 2024 ·Transfusion Medicine ·Andrea Heger, (unknown)	0
2	Thirty years of experience with solvent/detergent‐treated plasma for transfusion medicine 2024 ·Transfusion ·Sabrina Racine‐Brzostek, Melissa M. Cushing, (unknown), Andrea Heger, (unknown), Marie Scully	3
3	Frozen and freeze‐dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality 2022 ·Transfusion ·Andrea Heger, Gerhard Grüber	11
4	Thawing of Pooled, Solvent/Detergent-Treated Plasma octaplasLG®: Validation Studies Using Different Thawing Devices 2017 ·Transfusion Medicine and Hemotherapy ·Andrea Heger, Katharina Pock, Jürgen Römisch	8
5	Two solvent/detergent‐treated plasma products with a different biochemical profile 2016 ·ISBT Science Series ·(unknown), Andrea Heger	3
6	Five‐day stability of thawed plasma: solvent/detergent‐treated plasma comparable with fresh‐frozen plasma and plasma frozen within 24 hours 2015 ·Transfusion ·(unknown), (unknown), Andrea Heger, (unknown), Darrell J. Triulzi	25
7	Universal pooled plasma (Uniplas®) does not induce complement-mediated hemolysis of human red blood cells in vitro 2013 ·Transfusion and Apheresis Science ·Andrea Heger, (unknown), (unknown), (unknown), (unknown), Jürgen Römisch	6
8	Clotting factor activity in thawed Octaplas® LG during storage at 2–6°C for 6days from a quality assurance point of view 2012 ·Transfusion and Apheresis Science ·(unknown), Martin Krebs, Claudia Spies, Klaus‐Dieter Wernecke, Andrea Heger, Christian von Heymann	11
9	Removal of prion infectivity by affinity ligand chromatography during OctaplasLG^® manufacturing – results from animal bioassay studies 2011 ·Vox Sanguinis ·Andrea Heger, Andrew Bailey, (unknown), (unknown), Jürgen Römisch, (unknown)	9
10	Biochemical quality of the pharmaceutically licensed plasma OctaplasLG^® after implementation of a novel prion protein (PrP^Sc) removal technology and reduction of the solvent/detergent (S/D) process time 2009 ·Vox Sanguinis ·Andrea Heger, (unknown), (unknown), Sue Jordan, (unknown), Jürgen Römisch	51
11	Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)‐treated plasma OctaplasLG^® 2009 ·Vox Sanguinis ·(unknown), Andrew Bailey, Luisa Gregori, Andrea Heger, Sue Jordan, (unknown), (unknown), Jürgen Römisch, (unknown)	32
12	A biochemical quality study of a pharmaceutically licenced coagulation active plasma (Octaplas®) thawed by the SAHARA‐III dry tempering system compared to the regular use of a water bath 2007 ·Vox Sanguinis ·Andrea Heger, Jürgen Römisch, (unknown)	5
13	Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas®) and a development product (Uniplas®) 2007 ·Transfusion and Apheresis Science ·Katharina Pock, Andrea Heger, (unknown), (unknown), Jürgen Römisch	19
14	A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas®) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment 2006 ·Transfusion and Apheresis Science ·Andrea Heger, Jürgen Römisch, (unknown)	24
15	Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas®) and in the universally applicable plasma (Uniplas) in development 2006 ·Vox Sanguinis ·Andrea Heger, Christoph Kannicht, Jürgen Römisch, (unknown)	25
16	Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48h after thawing 2005 ·Transfusion and Apheresis Science ·Andrea Heger, Jürgen Römisch, (unknown)	25
17	Exact molecular mass determination of various forms of native and de‐N‐glycosylated human plasma‐derived antithrombin by means of electrospray ionization ion trap mass spectrometry 2004 ·Journal of Mass Spectrometry ·(unknown), Andrea Buchacher, Andrea Heger, Katharina Pock, Andreas Rizzi, Günter Allmaier	6
18	Characterization of antithrombin III from human plasma by two‐dimensional gel electrophoresis and capillary electrophoretic methods 2003 ·Electrophoresis ·Leopold Kremser, (unknown), Andrea Heger, Tom Grunert, Andrea Buchacher, Djuro Josić, Günter Allmaier, Andreas Rizzi	21
19	Separation of active and inactive forms of human antithrombin by heparin affinity chromatography 2002 ·Thrombosis Research ·Andrea Heger, Tom Grunert, Petra Schulz, Djuro Josić, Andrea Buchacher	22
20	Transient Pseudohypoaldosteronism Secondary to Posterior Urethral Valves - A Case Report and Review of the Literature 2001 ·European Journal of Pediatric Surgery ·(unknown), Tobias Schuster, Andrea Heger, Ursula Kuhnle, I. Joppich, (unknown)	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact